Редактирование: Aging genes 10-19 (раздел)

==TTR==

* {{medline-title
|title=Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration.
|date=04.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31728576
|full-text-url=https://sci-hub.do/10.1007/s00018-019-03357-1
}}
* {{medline-title
|title=Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
|date=14.12.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30552363
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294829
}}
* {{medline-title
|title=Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.
|date=02.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29209781
|full-text-url=https://sci-hub.do/10.1007/s00415-017-8668-8
}}
* {{medline-title
|title=The delaying effect of alpha-glycerophosphocholine on senescence, transthyretin deposition, and osteoarthritis in senescence-accelerated mouse prone 8 mice.
|date=04.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29191088
|full-text-url=https://sci-hub.do/10.1080/09168451.2017.1403883
}}
* {{medline-title
|title=Transthyretin deposition promotes progression of osteoarthritis.
|date=12.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28941045
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676063
}}
* {{medline-title
|title=Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.
|date=12.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28745065
|full-text-url=https://sci-hub.do/10.1177/1060028017723348
}}
* {{medline-title
|title=Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.
|date=2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26701417
|full-text-url=https://sci-hub.do/10.3109/13506129.2015.1115758
}}
* {{medline-title
|title=Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation.
|date=05.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26600212
|full-text-url=https://sci-hub.do/10.1002/lt.24371
}}
* {{medline-title
|title=Plasma concentrations of transthyretin in older Sardinians including centenarians.
|date=02.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25995168
|full-text-url=https://sci-hub.do/10.1007/s40520-015-0376-6
}}
* {{medline-title
|title=Transthyretin (A[[TTR]]) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
|date=09.2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25604431
|full-text-url=https://sci-hub.do/10.1136/jnnp-2014-308724
}}
* {{medline-title
|title=Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation.
|date=06.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24767952
|full-text-url=https://sci-hub.do/10.1016/j.thromres.2014.03.052
}}
* {{medline-title
|title=Physiological IgM class catalytic antibodies selective for transthyretin amyloid.
|date=09.05.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24648510
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036335
}}
* {{medline-title
|title=HuR and other turnover- and translation-regulatory RNA-binding proteins: implications for the kidney.
|date=15.03.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24431206
|full-text-url=https://sci-hub.do/10.1152/ajprenal.00270.2013
}}
* {{medline-title
|title=Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
|date=05.12.2013
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24182678
|full-text-url=https://sci-hub.do/10.1016/j.ijcard.2013.10.033
}}
* {{medline-title
|title=Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).
|date=12.2013
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24170234
|full-text-url=https://sci-hub.do/10.1007/s40266-013-0127-3
}}
* {{medline-title
|title=Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.
|date=19.03.2013
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23414091
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604100
}}